| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure M Packer, MR Bristow, JN Cohn, WS Colucci, MB Fowler, EM Gilbert, ... New England Journal of Medicine 334 (21), 1349-1355, 1996 | 6196 | 1996 |
| Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure MR Bristow, EM Gilbert, WT Abraham, KF Adams, MB Fowler, ... Circulation 94 (11), 2807-2816, 1996 | 1699 | 1996 |
| Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy F Waagstein, A Hjalmarson, K Swedberg, MR Bristow, EM Gilbert, ... The Lancet 342 (8885), 1441-1446, 1993 | 1580 | 1993 |
| Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure WS Colucci, M Packer, MR Bristow, EM Gilbert, JN Cohn, MB Fowler, ... Circulation 94 (11), 2800-2806, 1996 | 816 | 1996 |
| Consensus recommendations for the management of chronic heart failure: Introduction M Packer, JN Cohn, WT Abraham, WS Colucci, MB Fowler, BH Greenberg, ... American Journal of Cardiology 83 (2 A), 1A-38A, 1999 | 699 | 1999 |
| Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. BD Lowes, W Minobe, WT Abraham, MN Rizeq, TJ Bohlmeyer, RA Quaife, ... The Journal of clinical investigation 100 (9), 2315-2324, 1997 | 645 | 1997 |
| Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents BD Lowes, EM Gilbert, WT Abraham, WA Minobe, P Larrabee, ... New England Journal of Medicine 346 (18), 1357-1365, 2002 | 640 | 2002 |
| Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart EM Gilbert, WT Abraham, S Olsen, B Hattler, M White, P Mealy, ... Circulation 94 (11), 2817-2825, 1996 | 595 | 1996 |
| Effects of vesnarinone on morbidity and mortality in patients with heart failure AM Feldman, MR Bristow, WW Parmley, PE Carson, CJ Pepine, ... New England Journal of Medicine 329 (3), 149-155, 1993 | 563 | 1993 |
| Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. MR Bristow, RE Hershberger, JD Port, EM Gilbert, A Sandoval, ... Circulation 82 (2 Suppl), I12-25, 1990 | 500 | 1990 |
| Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study SL Olsen, EM Gilbert, DG Renlund, DO Taylor, FD Yanowitz, MR Bristow Journal of the American College of Cardiology 25 (6), 1225-1231, 1995 | 487 | 1995 |
| Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure BD Lowes, EA Gill, WT Abraham, JR Larrain, AD Robertson, MR Bristow, ... The American journal of cardiology 83 (8), 1201-1205, 1999 | 397 | 1999 |
| Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy MA Munger, B Johnson, IJ Amber, KS Callahan, EM Gilbert The American journal of cardiology 77 (9), 723-727, 1996 | 387 | 1996 |
| Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure CW Yancy, MB Fowler, WS Colucci, EM Gilbert, MR Bristow, JN Cohn, ... New England Journal of Medicine 344 (18), 1358-1365, 2001 | 384 | 2001 |
| Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. MR Bristow, JB O'Connell, EM Gilbert, WJ French, G Leatherman, ... Circulation 89 (4), 1632-1642, 1994 | 377 | 1994 |
| Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of … JL Anderson, EM Gilbert, BL Alpert, RW Henthorn, AL Waldo, ... Circulation 80 (6), 1557-1570, 1989 | 337 | 1989 |
| Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo EM Gilbert, JL Anderson, D Deitchman, FG Yanowitz, JB O'Connell, ... The American journal of medicine 88 (3), 223-229, 1990 | 313 | 1990 |
| A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy JL Anderson, JR Lutz, EM Gilbert, SG Sorensen, FG Yanowitz, ... The American journal of cardiology 55 (4), 471-475, 1985 | 312 | 1985 |
| The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial M Domanski, H Krause-Steinrauf, P Deedwania, D Follmann, JK Ghali, ... Journal of the American College of Cardiology 42 (5), 914-922, 2003 | 300 | 2003 |
| Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. SL Woodley, EM Gilbert, JL Anderson, JB O'connell, D Deitchman, ... Circulation 84 (6), 2426-2441, 1991 | 273 | 1991 |
